Professor Gerald Schatten
Professor Gerald Schatten is a leading international expert with interests in cell, developmental, and reproductive biology. Professor Gerald Schatten is Director of the Pittsburgh Development Center, Professor of Obstetrics, Gynecology and Reproductive Sciences, Cell Biology, Bioengineering and Director of the Division of Developmental and Regenerative Medicine, with join appointments also at the McGowan Institute and the Cancer Center, and member of the McGowan Institute for Regenerative Medicine. He is currently President of UNESCO’s International Cell Research Organization. He is extremely active in advanced research training and was one of the three founding directors of the FRONTIERS IN REPRODUCTION, the premier reproduction training vehicle for MD and PhDs. Professor Gerald Schatten is authors of 300 scientific papers on stem cells, regeneration, fertilization, cell biology, development, infertility, assisted reproductive technologies, as well as strategies for rectifying past injustices in scientific careers, have appeared in premier journals including Nature and Science. With extensive funding from the National Institutes of Health, Dr Schatten is the recipient of an NIH MERIT, and earlier Research Career Development Award, was honored by the Czech Academy of Sciences with their Purkinje Medal of Science, elected as a Delegate of the American Association for the Advancement of Sciences, a Mentor Awardee of the American Society for Cell Biology, elected Australian Society for Reproductive Biology President’s Lecturer, awarded the Daniel Mazia Award from Stanford University and a Doctor Honoris Causa (Honorary Doctorate) from the University of Nova Gorica, presented by the President of the Republic of Slovenia. His more recent research has focused on the use of human and primate stem cells to determine the potential of stem cell-based medical therapies and better understand cell and human development; the study of genetic versus epigenetic (environmental) causes for human disease.
Dr. Catherine Nguyen
Dr. Catherine Nguyen, Directrice de Recherche à l’ Inserm , is an adviser and expert in genomic, transcriptome, immunology and cancer research, DNA chips, splicing, molecular biology and Managing Director at French Institute of Health and Medical Research. She was Director of inserm-AMU UMR 1090 « Technologie Avancée pour le Génome et la Clinique; Co-leader of Plateforme Transcriptomique & Génomique Marseille Luminy (TGML) and Director of Institut Thématique Génétique, Génomique et Bioinformatique. Dr. Nguyen is a member of many societies/committee/organizations such as the committee of piloting of operation transcriptome of Marseilles Génopole, the Committee of Strategical Organization AGENAE INRA, the CHSHS PACA- INSERM, Human Genome Organisation, French Society of Immunology, Member of scientific comity of the Forum 2000, 2002, 2004, 2006 (Industrial meeting organization). Dr. Nguyen has published 89 research articles in international journals, 28 reviews and 3 book chapters; she is the author of patents on gene expression profiling of primary breast carcinomas using arrays of candidates’ genes (N°US 10-007 926) and gene expression profiling of blood tumors using polynucleotides arrays (International Extension PCT/IB01/02811. EP: 02290949.9).
Prof. Andras Dinnyes
Prof. Andras Janos Dinnyes is an international pioneer on embryology, genetic reprogramming by cloning and stem cells. He worked as team leader of the cloning team in Roslin Institute, Edinburgh, UK (the “Dolly team”) under Sir Ian Wilmut, he is author of the first gene knock-out lambs and cloned piglets in Europe. Prof. Dinnyes is member of the Stem Cell Committee of the Hungarian Academy of Sciences, the Medical Research Council Committee on Human Reproduction, board member of the Hungarian Biotechnology Association, the Hungarian Innovation Society and member of the Academia Europaea. In additional, Prof. Dinnyes works as an editor for the World Journal of Stem Cells and as Senior Editorial Board for the American Journal of Stem Cells. He has been published 342 scientific publications, including 191 full papers, 26 books/book chapters. For his pioneering and entrepreneurial work on genetic reprogramming technology, he has received the highest innovation award (“Denis Gabor Award”) in 2013. Since 2005, he is as founder and CEO in BioTalentum Ltd on animal and human stem cell research, transgenic cellular and animal models for biomedical, toxicology and pharma purposes. He has coordinated 14 EU projects in Systems Biology, human genetic reprogramming and epigenetics, long-term epigenetic health effects of human assisted reproductive technologies (ART), and Type-1 diabetes cellular therapy. Currently he is focusing on new human iPSC lines and their differentiation towards cardiac, neural, beta-cells and other cell types, including 3D culture.
Doctor Bạch Quốc Khánh
Doctor Bach Quoc Khanh – an excellent scientist and doctor in clinical hematology. Doctor Bach Quoc Khanh was awarded the title “People’s Physician” by the President of the Socialist Republic of Vietnam in 2025.
He has chaired and participated in the research of many scientific and technological topics and tasks at the State, Ministry and Institute levels that have been applied in practice. He and his colleagues have published over 150 prestigious articles in domestic and international medical journals. He won the “Vietnamese Talent” award for science and technology in 2016.
During his professional activities, he has held many important positions: the President of National Institute of Hematology and Blood Transfusion (NIHBT), Member of the Scientific Advisory Council for selection and acceptance of scientific and technological tasks at the Ministry and State levels; Member of the National Biomedical Research Ethics Council; Member of the Center’s Staff Health Care Protection Board; Member of the Institute’s Basic Science and Technology Council; Member of the Technical Evaluation Council of the Creative Sports Competition for Youth in the Health Sector.
Currently, he is President of the Vietnam Association of Hematology and Blood Transfusion, president of Vietnam Congenital Hemolytic Association, Deputy Head of the Department of Hematology and Blood Transfusion, Hanoi Medical University; Head of the Department of Hematology and Blood Transfusion, University of Medicine and Pharmacy, Vietnam National University.
Prof. Dr. Rangsun Parnpai
Prof. Dr. Rangsun Parnpai is Director of Embryo Tecchnology and Stem cell research center, School of Biotechnology, Suranaee University of Technology, Thailand. He is an internationally renowned expert on in vitro embryo production and embryo transfer, somatic cell cloning and is the first in Southeast Asia to successfully clone a cow. His cureent research focus on large-scale expansion of cord blood-derived NK cells, differentiation and transplantation of umblilical cord stem cells. He earned a Docroral degree in Animal Reproduction from Kyoto University, Japan and graduated in embryo transfer & in-vitro fertilisation from Cambridge University. He was the rotating president of the Asian Reproductive Biotechnoly Congress. His international experience includes various programs, contributions and participation in different countries (America, France, Japan,…) for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Prof. MVDr. Jan Motlík, DrSc.
Professor MVDr. Jan Motlík, DrSc., the former Director of the Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic (ASCR), is a leading scientist in both animal physiology and stem cell research. He has contributed considerably towards the establishment and organization of research activities in the field of stem cell research of the Grant Agency of the Czech Academy of Sciences, Centre of Cell Regeneration and Tissue Engineering, Laboratory of Cell Regeneration and Plasticity, and PIGMOD Research Center at the Institute of Animal Physiology and Genetics. Professor Jan Motlík has cooperated with Charles University, Prague, Institute of Macromolecular Chemistry, and the surgical teams from medical and veterinary schools, to develope methods of effective differentiation of minipig mesenchymal stem cells (MSCs) in chondrocytes, osteocytes and tendocytes, optimize a set of scaffolds for transfer of differentiating MSCs into growth plates, cartilage lesions and bone defects. The excellent results achieved with the minipig neural stem cells allowed him, in cooperation with the CHDI Foundation, to create the first transgenic minipig for the pharmaceutical studies of human mutated huntingtin. Professor Jan Motlík was a representative of the Czech Republic in ESDAR (European Society for Domestic Animal Reproduction, ICAR (International Congress of Animal Reproduction) and ESF- Life & Environmental Sciences, and is an active member of the European Huntington’s Disease Network (EHDN). He was rewarded by the Emil Přibyl Medal, twice he was presented with the Prize of the Czechoslovak Academy of and with the ARTA Award.